Display options
Share it on

Front Pharmacol. 2017 Aug 02;8:504. doi: 10.3389/fphar.2017.00504. eCollection 2017.

The Crux of the Medicine Prices' Controversy in Pakistan.

Frontiers in pharmacology

Kah S Lee, Adnan Shahidullah, Syed T R Zaidi, Rahul P Patel, Long C Ming, Muhammad H Tariq, Obaidullah Malik, Muhammad J Farrukh, Ahmad Khan, Siew M Yee, Tahir M Khan

Affiliations

  1. Pharmacy, School of Medicine, University of TasmaniaHobart, TAS, Australia.
  2. Department of Pharmacy, University of PeshawarPeshawar, Pakistan.
  3. School of Pharmacy, KPJ Healthcare University CollegeNilai, Malaysia.
  4. School of Pharmaceutical Sciences, Universiti Sains MalaysiaGelugor, Malaysia.
  5. Drug Regulatory Authority of PakistanIslamabad, Pakistan.
  6. Faculty of Pharmaceutical Sciences, UCSI UniversityKuala Lumpur, Malaysia.
  7. Department of Pharmacy, Faculty of Biological Sciences, Quaid-i-Azam UniversityIslamabad, Pakistan.
  8. Faculty of Pharmacy, SEGi UniversityKota Damansara, Malaysia.
  9. School of Pharmacy, Monash UniversitySunway City, Malaysia.

PMID: 28824429 PMCID: PMC5539127 DOI: 10.3389/fphar.2017.00504

[No abstract available.]

Keywords: consumer price index; delivery of health care; drug costs; health services accessibility; out-of-pocket expenditures

References

  1. Bull World Health Organ. 2007 Apr;85(4):279-88 - PubMed
  2. Lancet. 2009 Jan 17;373(9659):240-9 - PubMed
  3. PLoS One. 2013 May 22;8(5):e63515 - PubMed
  4. Lancet. 2016 Nov 26;388(10060):2602 - PubMed

Publication Types